Becker's Healthcare March 16, 2023
Noah Schwartz

The FDA has updated its guidance on using EHRs and electronic signatures in clinical trials to account for technological advances since the agency last updated its guidance in 2017, RegulatoryFocus reported March 15.

The updates provide recommendations for applying data integrity and data security tools to clinical trials.

The agency reiterated that sponsors and entities are responsible for ensuring that the records they submit through vendors comply with FDA regulations.

“In addition,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Clinical Trials, EMR / EHR, FDA, Govt Agencies, Health IT, Technology, Trends
Related Articles:
FDA wants to boost trial innovation with new center at CDER
Stelara biosimilar from Alvotech, Teva approved by FDA
Scopio Labs Receives FDA Clearance For AI-Driven Bone Marrow Analysis Application
STAT+: Grocers are pushing legislation they claim would enhance food safety. Advocates say it would gut FDA rules
Look Before You Leap - Early Determination Of Product Classification And Regulatory Pathway For FDA-Regulated Products

Share This Article